Graphjet Technology Regains Compliance with Nasdaq
July 31, 2024 08:00 ET
|
Graphjet Technology Sdn Bhd
KUALA LUMPUR, Malaysia, July 31, 2024 (GLOBE NEWSWIRE) -- Graphjet Technology (“Graphjet” or “the Company”) (Nasdaq:GTI), a leading developer of patented technologies to produce graphite and...
Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference
July 31, 2024 08:00 ET
|
Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, will participate in the BTIG...
ZimVie Announces the Release of RealGUIDE® 5.4 Software Update
July 31, 2024 08:00 ET
|
ZimVie Inc.
PALM BEACH GARDENS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced the release of its RealGUIDE® 5.4...
Columbia Financial, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2024
July 31, 2024 07:55 ET
|
Columbia Financial, Inc.
FAIR LAWN, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Columbia Financial, Inc. (the “Company”) (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank ("Columbia") and Freehold Bank...
Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research
July 31, 2024 07:44 ET
|
Clearmind Medicine Inc.
Vancouver, Canada, July 31, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
Cheer Holding Reports 2024 Half Year Results
July 31, 2024 07:37 ET
|
Cheer Holding, Inc.
BEIJING, July 31, 2024 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services,...
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
July 31, 2024 07:35 ET
|
ALTERITY THERAPEUTICS LIMITED
Highlights Positive interim data reported from ATH434-202 Phase 2 clinical trial showing improvement on the UMSARS Activities of Daily Living Scale and stable or improved neurological symptoms in...
Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation
July 31, 2024 07:30 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 12th annual Regeneron Prize for Creative Innovation (the...
LeddarTech Unveils the Future of ADAS With the European Launch of the LeddarNavigator Demo Car and Road Show
July 31, 2024 07:30 ET
|
LeddarTech inc.
QUEBEC CITY, Canada, July 31, 2024 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-based low-level...
LeddarTech dévoile l’avenir de l’ADAS avec le lancement européen du véhicule de démonstration LeddarNavigator et sa tournée de présentation
July 31, 2024 07:30 ET
|
LeddarTech inc.
QUÉBEC, Canada, 31 juill. 2024 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech ») (NASDAQ : LDTC), une société de logiciels automobiles qui fournit des technologies logicielles de...